Wanjian Gu

No.155, Hanzhong Road
Nanjing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 33 publications

Role of hepatocyte-derived fibrinogen-related protein 1 as a serum biomarker in the diagnosis of community-acquired pneumonia and sepsis: A cross-sectional study.

Role of hepatocyte-derived fibrinogen-related protein 1 as a serum biomarker in the diagnosis of community-acquired pneumonia and sepsis: A cross-sectional study.

Journal: The Journal of international medical research

Published: February 28, 2026

Peripheral blood-based S100P hypomethylation as a biomarker for the early-stage non-small cell lung cancer.

Peripheral blood-based S100P hypomethylation as a biomarker for the early-stage non-small cell lung cancer.

Journal: Epigenomics

Published: December 18, 2025

Fibrinogen-like protein 1 as a novel biomarker of rheumatoid arthritis and diagnostic basis for disease activity: a diagnostic test study.

Fibrinogen-like protein 1 as a novel biomarker of rheumatoid arthritis and diagnostic basis for disease activity: a diagnostic test study.

Journal: Clinical biochemistry

Published: September 26, 2025

The association between blood-based HYAL2 methylation and early-stage lung cancer: a case-control study.

The association between blood-based HYAL2 methylation and early-stage lung cancer: a case-control study.

Journal: Lung cancer management

Published: April 01, 2025

Gender-associated heterogeneity of F2RL3 methylation in peripheral blood highlights its associations with early-stage male lung cancer in the Chinese population.

Gender-associated heterogeneity of F2RL3 methylation in peripheral blood highlights its associations with early-stage male lung cancer in the Chinese population.

Journal: Cancer epidemiology

Published: March 20, 2025

Association between the methylations of RUNX3 in peripheral blood and lung cancer: a case-control study.

Association between the methylations of RUNX3 in peripheral blood and lung cancer: a case-control study.

Journal: Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals

Published: June 26, 2024

CCDC12 gene methylation in peripheral blood as a potential biomarker for breast cancer detection.

CCDC12 gene methylation in peripheral blood as a potential biomarker for breast cancer detection.

Journal: Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals

Published: May 22, 2024

Blood FOLR3 methylation dysregulations and heterogeneity in non-small lung cancer highlight its strong associations with lung squamous carcinoma.

Blood FOLR3 methylation dysregulations and heterogeneity in non-small lung cancer highlight its strong associations with lung squamous carcinoma.

Journal: Respiratory research

Published: September 30, 2023

The association between CTSZ methylation in peripheral blood and breast cancer in Chinese women.

The association between CTSZ methylation in peripheral blood and breast cancer in Chinese women.

Journal: Frontiers in oncology

Published: January 20, 2023

Untargeted Lipidomics Reveals Characteristic Biomarkers in Patients with Ankylosing Spondylitis Disease.

Untargeted Lipidomics Reveals Characteristic Biomarkers in Patients with Ankylosing Spondylitis Disease.

Journal: Biomedicines

Published: November 28, 2022

Hypomethylation of RPTOR in peripheral blood is associated with very early-stage lung cancer.

Hypomethylation of RPTOR in peripheral blood is associated with very early-stage lung cancer.

Journal: Clinica chimica acta; international journal of clinical chemistry

Published: September 07, 2022

Hypomethylation of DYRK4 in peripheral blood is associated with increased lung cancer risk.

Hypomethylation of DYRK4 in peripheral blood is associated with increased lung cancer risk.

Journal: Molecular carcinogenesis

Published: August 20, 2022

Showing 1-12 of 33

Last Updated: 09/26/2026